1 Biography information for Mrs Sharon Hodgson 17 MMR Vaccine 2017-01-31 false Health 2017-02-08T16:10:33.617Z Oxford West and Abingdon Nicola Blackwood false 2017-02-08 Biography information for Baroness Blackwood of North Oxford <p>In November 2016 a measles and rubella elimination strategy group was established to oversee the development of a United Kingdom-wide Measles and Rubella elimination strategy, which will outline the UK’s renewed commitment to the World Health Organization targets and make recommendations for further action.</p><p> </p><p>Public Health England (PHE) and NHS England work closely with providers at a local level to target specific communities where uptake of the Measles Mumps and Rubella vaccine is known to be poor, as well as widening access by commissioning a range of alternative providers to complement existing general practitioner activities and community health service delivered immunisations.</p><p> </p><p>PHE also contributes to national standard development and setting for immunisation providers and commissioners, which includes recommendations for commissioners and providers on increasing immunisation uptake among children and young people in groups and settings where immunisation coverage is low.</p> Mrs Sharon Hodgson Department of Health Health To ask the Secretary of State for Health, what steps he is taking to reach the WHO target of at least 95 per cent of children at age two are vaccinated for MMR. 62567 1 Washington and Sunderland West House of Commons Biography information for Andrew Stephenson 2017-03-23 To ask the Secretary of State for Health, how many children have received the MMR vaccination in each year since 2012 in (a) Pendle constituency, (b) Lancashire and (c) England. Department of Health 1 69035 MMR Vaccine false Health Andrew Stephenson 17 2017-03-30T14:05:06.403Z Oxford West and Abingdon Nicola Blackwood false 2017-03-30 <p>Annual uptake data is collected at national and local authority level; therefore data is available for Lancashire and England, but not Pendle constituency. The data can be found in the Cover of vaccination evaluated rapidly (COVER) programme reports, available at:</p><p><a href="https://www.gov.uk/government/collections/vaccine-uptake" target="_blank">https://www.gov.uk/government/collections/vaccine-uptake</a></p> Health Pendle MMR Vaccine 2019-02-08 false Biography information for Jo Stevens 2019-02-13T16:38:08.727Z Stourbridge Margot James false 2019-02-13 Biography information for Margot James <p>The Government takes all attempts to deliberately disrupt and confuse the information environment very seriously. It is difficult to attribute the slight decline in uptake of the MMR vaccinations to any one source, however, we will work with our colleagues in the Department of Health and Social Care and Public Health England to assess the impact that disinformation and manipulation of social and traditional media may have on this issue.</p> Digital, Culture, Media and Sport Digital, Culture, Media and Sport Jo Stevens 218819 10 Cardiff Central 1 Department for Digital, Culture, Media and Sport To ask the Secretary of State for Digital, Culture, Media and Sport, whether his Department has made an assessment of the role of social and traditional media in the decline in levels of uptake of the MMR vaccination. Health and Social Care Mr Jim Cunningham MMR Vaccine Biography information for Mr Jim Cunningham 241384 2019-04-05 1 Health and Social Care To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the child MMR vaccination rates. 17 Department of Health and Social Care Coventry South false 2019-04-10T13:26:53.66Z South Ribble Seema Kennedy false 2019-04-10 Biography information for Seema Kennedy <p>Public Health England routinely monitors coverage for the national immunisation programme, including the measles, mumps and rubella (MMR) vaccine on a quarterly and annual basis.</p><p> </p><p>National coverage figures reported for the MMR first dose as measured at five years show coverage, which reached the World Health Organization recommended target level of 95% for the first-time last year, was 94.9% in England in 2017-18. Uptake of the second MMR dose by age five years in England was 87.2%. The 2017/18 data can be viewed at the following link:</p><p> </p><p><a href="https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf" target="_blank">https://files.digital.nhs.uk/55/D9C4C2/child-vacc-stat-eng-2017-18-report.pdf</a></p> Health and Social Care false Biography information for Emma Reynolds 2019-06-24T16:57:13.03Z South Ribble Seema Kennedy false 2019-06-24 South Ribble Seema Kennedy <p>There has been an increase in cases of measles since the end of 2017 with close to 1,000 cases reported in 2018. However, the majority of these cases (628/966, 65%) are in individuals aged less than one year old and over 15 years i.e. those not in recently vaccinated age cohorts. Data is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2018" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2018</a></p><p>An increase in mumps activity was observed in England in the first quarter (Q1) of 2019 with 795 laboratory confirmed mumps infections. Almost half (352/795, 44%) of the cases in Q1 were in unvaccinated individuals. This data can be viewed at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804024/hpr1819_mmr2.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804024/hpr1819_mmr2.pdf</a></p><p>The World Health Organization confirmed that the United Kingdom had eliminated rubella in 2015. Between 2013-18 there were only 10 laboratory confirmed cases in England. This data can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter" target="_blank">https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter</a></p><p>Nearly all these cases have been in individuals born abroad and were not eligible to receive rubella containing vaccine in United Kingdom.</p> Health and Social Care Emma Reynolds 2019-06-13 Department of Health and Social Care Wolverhampton North East 264387 To ask the Secretary of State for Health and Social Care, what assessment he has made of the correlation between falling rates of vaccination for measles, mumps and rubella and the increased incidence of those conditions. 17 MMR Vaccine 1 Gravesham 17 280999 Department of Health and Social Care MMR Vaccine Health and Social Care 2019-07-23 Adam Holloway Health and Social Care false To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine. Biography information for Adam Holloway 1 2019-07-25T16:38:57.347Z Thurrock Jackie Doyle-Price false 2019-07-25 Biography information for Dame Jackie Doyle-Price <p>Two Measles, Mumps and Rubella (MMR) vaccines are licensed for use in the United Kingdom: M-M-RVaxPro and Priorix. Both vaccines are on the National Health Service’s routine immunisation schedule. The quality, safety and efficacy of both M-M-RVaxPro and Priorix have been evaluated before they were given a Marketing Authorisation in Europe, and the Marketing Authorisation Holder for each vaccines is legally required to submit periodic safety update reports to the regulator, which are documents intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points after its authorisation. The sites at which the products are manufactured are also required to undergo periodic inspections to ensure that they comply with Good Manufacturing Practices. Each batch of vaccines is tested by an official medicines control laboratory (OMCL). OMCL testing is independent of and in addition to the manufacturer’s testing. These procedures ensure that the MMR vaccines available in the UK are safe and efficacious and that the manufacturers/Marketing Authorisation holders are held accountable for their products.</p><p>A European Public Assessment Report (EPAR) for M-M-RVaxPro is available at the following link:</p><p><a href="https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf" target="_blank">https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf</a></p><p>Priorix was approved before public assessment reports were a requirement. The EPAR for M-M-RVaxPro contains a general summary of the manufacturing information that was provided during the assessment process; however, the specific details of the manufacturing process are confidential.</p> 2019-07-24 Health and Social Care 17 Adam Holloway 1 false 281668 Department of Health and Social Care Health and Social Care MMR Vaccine To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that parents and carers are provided with accurate information on the benefits and risks of the MMR vaccine. 2019-09-09T14:56:52.257Z Bury St Edmunds Jo Churchill false 2019-09-09 Biography information for Jo Churchill <p>The National Health Service website has a dedicated page on the measles, mumps and rubella (MMR) vaccine, which can be found at the following link:</p><p><a href="https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/" target="_blank">https://www.nhs.uk/conditions/vaccinations/mmr-vaccine/</a></p><p>In addition, Public Health England provides information on the benefits and risks of the MMR vaccine to the public using NHS branded leaflets, some of which are available in multiple languages. The leaflets address common questions about the MMR vaccine. In addition to parents and carers this information is designed for use by schools, healthcare centres, accident and emergency departments, hospital wards, walk-in centres and general practices.</p> Gravesham Jim Fitzpatrick Poplar and Limehouse To ask the Secretary of State for Health and Social Care, whether his Department has assessed the potential effect on public health of allowing children who have not received the MMR vaccine to start primary school in September 2019. 1 Health and Social Care false 17 2019-10-01 Department of Health and Social Care 2019-10-08T15:24:49.433Z Bury St Edmunds Jo Churchill false 2019-10-08 <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p><p> </p> 292818 Health and Social Care MMR Vaccine 292817 Biography information for Jim Fitzpatrick 1 Department of Health and Social Care 2019-10-08T15:24:49.497Z Bury St Edmunds Jo Churchill false 2019-10-08 <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p><p> </p> 292817 MMR Vaccine false 292818 Health and Social Care Poplar and Limehouse 2019-10-01 Jim Fitzpatrick 17 To ask the Secretary of State for Health and Social Care, whether his Department plans to prevent children who have not received the MMR vaccine from attending school. Health and Social Care 1 Biography information for Mr Gregory Campbell Health and Social Care East Londonderry Department of Health and Social Care 2020-02-10 Mr Gregory Campbell 14630 MMR Vaccine 17 To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the uptake of the measles, mumps and rubella vaccine in the last five years. false Health and Social Care 2020-02-13T17:03:51.397Z Bury St Edmunds Jo Churchill false 2020-02-13 <p>Between 2013/14 and 2018/19 coverage for one Measles, Mumps and Rubella (MMR) vaccine dose at 24 months decreased 2.4% points from 92.7% to 90.3%. Coverage for two doses, at five years of age, decreased 1.9% points from 88.3% in 2013/14 to 86.4% in 2018/19. Coverage of the first dose by five years of age in England has been more or less stable from 2015 to 2018 reaching the World Health Organization’s target level of 95% for the first-time in 2016-17 but dropping to 94.9% in 2017-18.</p><p> </p><p>The following table shows uptake of the MMR vaccine at first dose at 24 months and in five year olds, and second dose in five year olds in England since 2013/14.</p><p> </p><table><tbody><tr><td><p>-</p></td><td><p>24 months</p></td><td><p>Five years</p></td><td><p>Five years</p></td></tr><tr><td><p>-</p></td><td><p>% MMR (1st Dose)</p></td><td><p>% MMR (1st Dose)</p></td><td><p>% MMR (1st and 2nd Dose)</p></td></tr><tr><td><p>2013-14</p></td><td><p>92.7</p></td><td><p>94.1</p></td><td><p>88.3</p></td></tr><tr><td><p>2014-15</p></td><td><p>92.3</p></td><td><p>94.4</p></td><td><p>88.6</p></td></tr><tr><td><p>2015-16</p></td><td><p>91.9</p></td><td><p>94.8</p></td><td><p>88.2</p></td></tr><tr><td><p>2016-17</p></td><td><p>91.6</p></td><td><p>95.0</p></td><td><p>87.6</p></td></tr><tr><td><p>2017-18</p></td><td><p>91.2</p></td><td><p>94.9</p></td><td><p>87.2</p></td></tr><tr><td><p>2018-19</p></td><td><p>90.3</p></td><td><p>94.5</p></td><td><p>86.4</p></td></tr></tbody></table><p>Source:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2018-19" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2018-19</a></p><p> </p> 34 10 0